ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
8393 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter ETH Entrepreneurship
MOBIS-COVID19/75 - Research Collection
... Mobilitätsverhalten herangezogen. Diese 4 Wochen beginnen je nach Teilnehmer irgendwo zwischen dem 1. September und ... MOBIS-COVID19/ 75 - Research Collection ... MOBIS-COVID19/ 75 - Research Collection Header Upper Right Menu Log in de Research Collection Toggle ... MOBIS-COVID19/ 75 - Research Collection ...
Russian Analytical Digest No 75: Russian-Ukrainian Relations
... Russian Analytical Digest No 75: Russian-Ukrainian Relations No. 75 analytical digest 16 March 2010 ... analytical digest 75/10 analysis Back to the Future? Ukrainian-Russian■Relations■After■Kyiv’s■Presidential ... Russian Analytical Digest No 75: Russian-Ukrainian Relations ... Russian Analytical Digest No 75: Russian-Ukrainian Relations No. 75 analytical digest 16 March 2010 ... Russian Analytical Digest No 75: Russian-Ukrainian Relations ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
497 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter CSL Vifor
CSL Annual Report 2023 – Page 75
... 1 74 Table of Contents 76 172 CSL Annual Report 2023 12 Key Performance Data Summary Performance ... Absolutes§ Energy consumption Petajoules 3.73 3.92 4.21†^ 47 Scope 1 & 2 greenhouse gas emissions Metric ... CSL Annual Report 2023 – Page 75 1 74 Table of Contents 76 172 CSL Annual Report 2023 12 Key ... CSL Annual Report 2023 – Page 75 ... CSL Annual Report 2023 – Page 75 ...
CSL Annual Report 2022 – Page 75
... 1 74 Table of Contents 76 156 CSL Annual Report 2022 2. 2022 Key Management Personnel Remuneration ... CSL Annual Report 2022 – Page 75 1 74 Table of Contents 76 156 CSL Annual Report 2022 2. 2022 Key ... CSL Annual Report 2022 – Page 75 ... CSL Annual Report 2022 – Page 75 ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
10442 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter University of Zurich
Fracture Epidemiology Among Individuals 75+ - Zurich Open Repositor...
... % for men ( 1). After age 75, hip fractures are the most frequent fractures, and up to 50% of older ... increase in hip fractures after age 75 translates into an estimated 1 in 3 women, and 1 in 6 men, who will ... % for men ( 1). After age 75, hip fractures are the most frequent fractures, and up to 50% of older ... increase in hip fractures after age 75 translates into an estimated 1 in 3 women, and 1 in 6 men, who will ... Fracture Epidemiology Among Individuals 75+ - Zurich Open Repository and Archive ...
UZH - Geographisches Institut - #75: How roots influence climate change
... 08.09.2020 # 75: How roots influence climate change Since the Holocene epoch, we benefit from a ... involving soils. Day 1: Start of the experiment in the climate chamber / Day 27: N fertilizer application ... UZH - Geographisches Institut - # 75: How roots influence climate change ... UZH - Geographisches Institut - # 75: How roots influence climate change Home Hauptnavigation Suche ... UZH - Geographisches Institut - # 75: How roots influence climate change ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
18680 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter Somagenetix
Effect of desogestrel 75 µg on headache frequency and intensity in ...
... desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial ... . Several studies have reported a reduction in migraine frequency and intensity with desogestrel 75 µg, a ... Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a ... Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a ... Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a ...
Statement complementing the EFSA Scientific Opinion on application ...
... ‐2009‐ 75) for placing on the market of genetically modified oilseed rape Ms8 × Rf3 × GT73 and ... Scientific Opinion on application (EFSA‐GMO‐NL‐2009‐ 75) for placing on the market of genetically modified ... Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2009‐ 75) for ... Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2009‐ 75) for ... Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2009‐ 75) for ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
305 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter Blutspende SRK Zürich
2013-GASSNER-weak D type 45.1-75-76_DGTi-Münster
... 2013-GASSNER-weak D type 45.1- 75-76_DGTi-Münster NEW RHD ALLELES WITH WEAK HEMAGGLUTINATION AND ... GENETIC EXON 9 DIVERSITY: weak D TYPES 45.1, 75, AND 76. Christoph Gassner1, Irene Utz2, Harald Schennach2 ... 2013-GASSNER-weak D type 45.1- 75-76_DGTi-Münster ... %20D%20type%2045.1- 75-76_DGTi-Mu%CC%88nster.pdf ... 2013-GASSNER-weak D type 45.1- 75-76_DGTi-Münster ...
Folie 1
... Folie 1 IRON DEPLETION DYNAMICS AND SAFETY OF THERAPEUTIC ERYTHROCYTAPHERESIS VERSUS CONVENTIONAL ... ) ). Tolerability and side effects were recorded using a standardized questionaire and a rating system. 1. M ... Folie 1 ... Folie 1 IRON DEPLETION DYNAMICS AND SAFETY OF THERAPEUTIC ERYTHROCYTAPHERESIS VERSUS CONVENTIONAL ... Folie 1 ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
832 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter University Hospital Zurich, Research and Education Office
Slide S III 1
... aortic valve ICD-10: I35.8 S III 1 Mann, 75 J., Synkopen, Aortenstenose. Autopsiepräparat ... lymphozytären Infiltraten 75-year-old male. Syncope. Aortic stenosis. Autopsy specimen. Macroscopically ... aortic valve ICD-10: I35.8 S III 1 Mann, 75 J., Synkopen, Aortenstenose. Autopsiepräparat ... unregelmässig auf - Weitlumig-dünnwandige Blutgefässe umgeben von diskreten lymphozytären Infiltraten 75-year ... Slide S III 1 ...
Slide S VIII 1
... Akuter Niereninfarkt renal infarction HE renal infarction ICD-10: N28.0 Mann, 75 J ... grösseren Gefässen geringe Intimafibrose bzw. Arteriosklerose 75-year-old male with atrial fibrillation ... Mann, 75 J., Vorhofflimmern, Exitus bei Myokardinfarkt. Autopsie. - Umschriebenes nekrotisches Areal ... Gefässen geringe Intimafibrose bzw. Arteriosklerose 75-year-old male with atrial fibrillation. Death ... Slide S VIII 1 ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
2463 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter Roche Glycart AG
OP-EHEA190412 1..61
... OP-EHEA190412 1..61 2019 ESC Guidelines for the diagnosis and management of acute pulmonary ... Mainz, Building 403, Langenbeckstr. 1, 55131 Mainz, Germany. Tel: þ49 613 117 6255, Fax: þ49 613 117 ... OP-EHEA190412 1..61 ... OP-EHEA190412 1..61 2019 ESC Guidelines for the diagnosis and management of acute pulmonary ... OP-EHEA190412 1..61 ...
腫瘍微小環境 | ロシュ・ダイアグノスティックス
... of the PD-L1/PD- 1 pathway to T-cell exhaustion: an update on implications for chronic infections and ... 腫瘍 微小環境 | ロシュ・ダイアグノスティックス ... 腫瘍 微小環境 | ロシュ・ダイアグノスティックス あなたはこのサイト上での十分な体験を阻害しうる匿名/プライベートブラウジングモードもしくは広告除去ソフトを使用しているようです。広告除去ソフトを無効 ... 腫瘍 微小環境 | ロシュ・ダイアグノスティックス ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
276 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter InSphero AG
Slide 1
... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... 0 = M4 32 .8 IC 5 0 = M1 90 .9 IC 5 0 = M3 48 . 1 H u m a n H e p /H u m a n N P C 1 1 0 1 0 0 1 0 ... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... 0 = M4 32 .8 IC 5 0 = M1 90 .9 IC 5 0 = M3 48 . 1 H u m a n H e p /H u m a n N P C 1 1 0 1 0 0 1 0 ... Slide 1 ...
Folie 1
... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 ...
Surgical Fusion Technologies GmbH
8952 Schlieren, Wagistrasse 6
+41 (0)44 204 61 21
Surgical Fusion Technologies is a technology and development company specialized in medical and surgical product innovations. SFT products are based on Suprafusion technology, a disruptive soft tissue fixation system using a unique ultrasonic generator to deliver next-generation anchoring solutions that seek to eliminate anchor micro-motion, leading to greater fixation stability, and improved healing outcomes.
Surgical Fusion Technologies GmbH
Wagistrasse 6
8952 Schlieren
1 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter Surgical Fusion Technologies GmbH
Terms of Service 1 — company
... Terms of Service 1 — company ... Terms of Service 1 — company 0 Skip to Content Home Technology Company Contact Open Menu Close Menu ... Terms of Service 1 — company ...
Dinamiqs – a Siegfried company
8952 Schlieren, Wagistrasse 25
We are a science-driven contract development and manufacturing organization offering end-to-end viral vector manufacturing solutions. We offer customized services for companies and institutions developing innovative genetic medicines. As a science and technology-driven platform, we provide a comprehensive approach to viral vector manufacturing, from lab-scale development to scalable bioreactor implementation, process optimization, formulation, and stringent quality control.
Dinamiqs – a Siegfried company
Wagistrasse 25
8952 Schlieren
7 Ergebnisse für "怎么查酒店开房信息- 查询微信1 75" unter Dinamiqs – a Siegfried company
Celebrating 1 year as Siegfried DINAMIQS - DINAMIQS
... Celebrating 1 year as Siegfried DINAMIQS It’s been an exciting year since we joined the Siegfried ... Celebrating 1 year as Siegfried DINAMIQS - DINAMIQS ... https://dinamiqs.com/celebrating- 1-year-as-siegfried-dinamiqs/ ... Celebrating 1 year as Siegfried DINAMIQS - DINAMIQS ...
... [ 1]. We optimized upstream production parameters and downstream purification using MP, identifying ... ) Condition No. Plasmid ratio (pRep2Cap5:pGOI:pHelper) pHelper % Full Titer ddPCR (vg/ml) Total VGs 1 1: 1: 1 ... [ 1]. We optimized upstream production parameters and downstream purification using MP, identifying ... ) Condition No. Plasmid ratio (pRep2Cap5:pGOI:pHelper) pHelper % Full Titer ddPCR (vg/ml) Total VGs 1 1: 1: 1 ...
